Probuphine (buprenorphine) Drug Interactions
A total of 628 drugs are known to interact with Probuphine (buprenorphine).
- 189 major drug interactions
- 434 moderate drug interactions
- 5 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Probuphine (buprenorphine) and the medicines listed below.
- Abilify MyCite (aripiprazole)
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Afinitor Disperz (everolimus)
- Afstyla (antihemophilic factor)
- Aggrenox (aspirin / dipyridamole)
- Akynzeo (netupitant / palonosetron)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- Alprazolam Intensol (alprazolam)
- Amicar (aminocaproic acid)
- amoxicillin
- ibuprofen
- Klonopin (clonazepam)
- Lasix (furosemide)
- Levemir (insulin detemir)
Probuphine (buprenorphine) alcohol/food interactions
There is 1 alcohol/food interaction with Probuphine (buprenorphine)
Probuphine (buprenorphine) disease interactions
There are 15 disease interactions with Probuphine (buprenorphine) which include:
- impaired GI motility
- infectious diarrhea
- liver disease
- prematurity
- gastrointestinal obstruction
- acute MI
- drug dependence
- intracranial pressure
- respiratory depression
- adrenal insufficiency
- biliary spasm
- hypothyroidism
- renal dysfunction
- seizure disorders
- urinary retention
More about Probuphine (buprenorphine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (3)
- FDA Approval History
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.